Assignee profile:

Samumed, LLC

City:

San Diego, California

Country:

United States

Published Applications:

114

Last publication date:

2021-01-07

Patent Grants:

114

Last grant date:

2021-04-20

Top Inventors for applications by Samumed, LLC

These are the the leading inventors for applications assigned to Samumed, LLC:

Recent patent applications by Samumed, LLC

Samumed, LLC based in San Diego, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-01-07 ✅ Patent 10,981,909 granted on 2021-04-20
US20210002273A1
Chemistry; metallurgy

Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide

#2 | 2020-10-15 ✅ Patent 10,882,860 granted on 2021-01-05
US20200325133A1
Chemistry; metallurgy

Treatment of osteoarthritis

#3 | 2020-09-24 ✅ Patent 10,947,217 granted on 2021-03-16
US20200299263A1
Chemistry; metallurgy

Isoquinolin-3-YL carboxamides and preparation and use thereof

#4 | 2020-07-16 ✅ Patent 11,034,682 granted on 2021-06-15
US20200223834A1
Chemistry; metallurgy

Gamma-diketones as wnt/β-catenin signaling pathway activators

#5 | 2020-06-18 ✅ Patent 10,947,228 granted on 2021-03-16
US20200190082A1
Chemistry; metallurgy

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

#6 | 2020-05-21 ✅ Patent 10,744,128 granted on 2020-08-18
US20200155540A1
Human necessities

6-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereof

#7 | 2019-12-19 ✅ Patent 10,759,799 granted on 2020-09-01
US20190382402A1
Chemistry; metallurgy

Indazole containing macrocycles and therapeutic uses thereof

#8 | 2019-11-21 ✅ Patent 10,654,832 granted on 2020-05-19
US20190352279A1
Chemistry; metallurgy

3-(benzoimidazol-2-YL)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof

#9 | 2019-08-29 ✅ Patent 10,934,297 granted on 2021-03-02
US20190263821A1
Chemistry; metallurgy

5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof

#10 | 2019-08-01 ✅ Patent 10,544,128 granted on 2020-01-28
US20190233396A1
Chemistry; metallurgy

Isoquinolin-3-yl carboxamides and preparation and use thereof

#11 | 2019-06-27 ✅ Patent 10,633,380 granted on 2020-04-28
US20190194187A1
Chemistry; metallurgy

Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-C]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide

#12 | 2019-05-09 ✅ Patent 10,342,788 granted on 2019-07-09
US20190134013A1
Human necessities

1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof

#13 | 2019-05-02 ✅ Patent 10,703,748 granted on 2020-07-07
US20190127370A1
Chemistry; metallurgy

Diazanaphthalen-3-yl carboxamides and preparation and use thereof

#14 | 2019-05-02 ✅ Patent 10,413,537 granted on 2019-09-17
US20190125741A1
Human necessities

6-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereof

#15 | 2019-05-02 ✅ Patent 10,653,688 granted on 2020-05-19
US20190125740A1
Human necessities

6-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereof

#16 | 2019-04-25 ✅ Patent 10,526,347 granted on 2020-01-07
US20190119303A1
Chemistry; metallurgy

3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof

#17 | 2019-04-25 ✅ Patent 10,604,514 granted on 2020-03-31
US20190119263A1
Chemistry; metallurgy

6-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereof

#18 | 2019-04-18 ✅ Patent 10,544,139 granted on 2020-01-28
US20190112304A1
Chemistry; metallurgy

Treatment of osteoarthritis

#19 | 2019-03-07 ✅ Patent 10,407,425 granted on 2019-09-10
US20190071440A1
Chemistry; metallurgy

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

#20 | 2019-02-21 ✅ Patent 10,280,166 granted on 2019-05-07
US20190055238A1
Chemistry; metallurgy

2-(1H-indazol-3-yl)-3H-imidazo[4,5-B]pyridine and therapeutic uses thereof

#21 | 2019-02-21 ✅ Patent 10,457,672 granted on 2019-10-29
US20190055227A1
Chemistry; metallurgy

γ-diketones as Wnt/β-catenin signaling pathway activators

#22 | 2018-12-27 ✅ Patent 10,519,169 granted on 2019-12-31
US20180370989A1
Chemistry; metallurgy

3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof

#23 | 2018-11-22 ✅ Patent 10,314,832 granted on 2019-06-11
US20180333400A1
Human necessities

β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators

#24 | 2018-11-15 ✅ Patent 10,206,929 granted on 2019-02-19
US20180325910A1
Human necessities

3-(1H-imidazo[4,5-c]pyridin-2-yl)-1H-pyrazolo[3,4-b]pyridine and therapeutic uses thereof

#25 | 2018-11-08 ✅ Patent 10,899,757 granted on 2021-01-26
US20180318292A1
Human necessities

2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof

#26 | 2018-09-13 ✅ Patent 10,105,370 granted on 2018-10-23
US20180256588A1
Human necessities

1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof

#27 | 2018-09-06 ✅ Patent 10,596,154 granted on 2020-03-24
US20180250269A1
Human necessities

3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

#28 | 2018-08-23 ✅ Patent 10,464,924 granted on 2019-11-05
US20180237416A1
Chemistry; metallurgy

Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors

#29 | 2018-08-16 ✅ Patent 10,392,383 granted on 2019-08-27
US20180230142A1
Chemistry; metallurgy

3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof

#30 | 2018-08-16 ✅ Patent 10,206,909 granted on 2019-02-19
US20180228785A1
Human necessities

3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof

#31 | 2018-08-16 ✅ Patent 10,226,453 granted on 2019-03-12
US20180228784A1
Human necessities

3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof

#32 | 2018-08-16 ✅ Patent 10,285,983 granted on 2019-05-14
US20180228783A1
Human necessities

3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof

#33 | 2018-08-16 ✅ Patent 10,285,982 granted on 2019-05-14
US20180228782A1
Human necessities

3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof

#34 | 2018-08-16 ✅ Patent 10,166,218 granted on 2019-01-01
US20180228781A1
Human necessities

3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof

#35 | 2018-08-09 ✅ Patent 10,329,309 granted on 2019-06-25
US20180222923A1
Chemistry; metallurgy

3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof

#36 | 2018-08-09 ✅ Patent 10,604,512 granted on 2020-03-31
US20180222891A1
Chemistry; metallurgy

3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof

#37 | 2018-08-09 ✅ Patent 10,556,885 granted on 2020-02-11
US20180222887A1
Chemistry; metallurgy

Isoquinolin-3-YL carboxamides and preparation and use thereof

#38 | 2018-08-09 ✅ Patent 10,188,634 granted on 2019-01-29
US20180221354A1
Human necessities

3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof

#39 | 2018-08-09 ✅ Patent 10,195,185 granted on 2019-02-05
US20180221353A1
Human necessities

3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof

#40 | 2018-08-09 ✅ Patent 10,463,651 granted on 2019-11-05
US20180221350A1
Human necessities

3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof

#41 | 2018-08-09 ✅ Patent 10,226,448 granted on 2019-03-12
US20180221341A1
Human necessities

3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof

#42 | 2018-08-02 ✅ Patent 10,081,631 granted on 2018-09-25
US20180215753A1
Chemistry; metallurgy

2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof

#43 | 2018-08-02 ✅ Patent 10,231,956 granted on 2019-03-19
US20180214429A1
Human necessities

3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof

#44 | 2018-08-02 ✅ Patent 10,206,908 granted on 2019-02-19
US20180214427A1
Human necessities

3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof

#45 | 2018-07-26 ✅ Patent 10,287,267 granted on 2019-05-14
US20180208580A1
Chemistry; metallurgy

Isoquinolin-3-yl carboxamides and preparation and use thereof

#46 | 2018-07-26 ✅ Patent 10,350,199 granted on 2019-07-16
US20180207141A1
Human necessities

3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof

#47 | 2018-07-19 ✅ Patent 10,533,020 granted on 2020-01-14
US20180201624A1
Chemistry; metallurgy

3-(3H-imidazo[4,5-B]pyridin-2-yl)-1 H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

#48 | 2018-07-12 ✅ Patent 10,434,052 granted on 2019-10-08
US20180193244A1
Human necessities

Gamma-diketones for treatment and prevention of aging skin and wrinkles

#49 | 2018-07-05 ✅ Patent 10,806,726 granted on 2020-10-20
US20180185343A1
Human necessities

Methods of using indazole-3-carb oxamides and their use as Wnt/B-catenin signaling pathway inhibitors

#50 | 2018-06-28 ✅ Patent 10,052,331 granted on 2018-08-21
US20180177787A1
Human necessities

3-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

#51 | 2018-06-14 ✅ Patent 10,183,929 granted on 2019-01-22
US20180162840A1
Chemistry; metallurgy

3-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof

#52 | 2018-06-07 ✅ Patent 10,100,038 granted on 2018-10-16
US20180155323A1
Chemistry; metallurgy

Isoquinolin-3-yl carboxamides and preparation and use thereof

#53 | 2018-06-07 ✅ Patent 10,016,406 granted on 2018-07-10
US20180153873A1
Human necessities

Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof

#54 | 2018-05-31 ✅ Patent 10,023,572 granted on 2018-07-17
US20180148444A1
Chemistry; metallurgy

2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof

#55 | 2018-05-24 ✅ Patent 10,131,677 granted on 2018-11-20
US20180141963A1
Chemistry; metallurgy

3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof

#56 | 2018-05-17 ✅ Patent 10,758,523 granted on 2020-09-01
US20180133199A1
Human necessities

Single-dose, ready-to-use injectable formulations

#57 | 2018-05-10 ✅ Patent 10,669,240 granted on 2020-06-02
US20180127377A1
Chemistry; metallurgy

5-substituted indazole-3-carboxamides and preparation and use thereof

#58 | 2018-04-05 ✅ Patent 9,951,048 granted on 2018-04-24
US20180093970A1
Chemistry; metallurgy

Isoquinolin-3-yl carboxamides and preparation and use thereof

#59 | 2018-03-29 ✅ Patent 10,202,377 granted on 2019-02-12
US20180086754A1
Chemistry; metallurgy

3-(1H-benzo[D]imidazol-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

#60 | 2017-12-07 ✅ Patent 10,072,004 granted on 2018-09-11
US20170349584A1
Chemistry; metallurgy

Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo [4,5-C]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide

#61 | 2017-11-23 ✅ Patent 10,071,086 granted on 2018-09-11
US20170333409A1
Human necessities

1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof

#62 | 2017-11-02 ✅ Patent 10,106,527 granted on 2018-10-23
US20170313682A1
Chemistry; metallurgy

Isoquinolin-3-yl carboxamides and preparation and use thereof

#63 | 2017-11-02 ✅ Patent 10,508,099 granted on 2019-12-17
US20170313681A1
Chemistry; metallurgy

Isoquinolin-3-yl carboxamides and preparation and use thereof

#64 | 2017-09-21 ✅ Patent 9,844,536 granted on 2017-12-19
US20170267697A1
Chemistry; metallurgy

3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

#65 | 2017-09-14 ✅ Patent 9,815,854 granted on 2017-11-14
US20170260209A1
Chemistry; metallurgy

3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

#66 | 2017-09-14 ✅ Patent 9,828,372 granted on 2017-11-28
US20170260179A1
Chemistry; metallurgy

2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof

#67 | 2017-09-14 ✅ Patent 9,951,053 granted on 2018-04-24
US20170260176A1
Chemistry; metallurgy

γ-diketones as Wnt/β-catenin signaling pathway activators

#68 | 2017-08-31 ✅ Patent 9,884,053 granted on 2018-02-06
US20170246154A1
Human necessities

β- and γ-diketones and γ-hydroxyketones as /β-catenin signaling pathway activators

#69 | 2017-08-10 ✅ Patent 9,889,140 granted on 2018-02-13
US20170224697A1
Human necessities

3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof

#70 | 2017-08-03 ✅ Patent 9,763,951 granted on 2017-09-19
US20170216299A1
Human necessities

3-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

#71 | 2017-07-20 ✅ Patent 9,855,272 granted on 2018-01-02
US20170202846A1
Human necessities

1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof

#72 | 2017-03-09 ✅ Patent 9,763,927 granted on 2017-09-19
US20170065574A1
Human necessities

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

#73 | 2016-11-03 ✅ Patent 9,586,977 granted on 2017-03-07
US20160318954A1
Chemistry; metallurgy

1H-pyrazolo[3,4-]pyridines and therapeutic uses thereof

#74 | 2016-10-20 ✅ Patent 9,802,916 granted on 2017-10-31
US20160304488A1
Chemistry; metallurgy

Indazole-3-carboxamides and their use as Wnt/beta-catenin signaling pathway inhibitors

#75 | 2016-10-13 ✅ Patent 9,994,563 granted on 2018-06-12
US20160297812A1
Chemistry; metallurgy

Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof

#76 | 2016-07-21 ✅ Patent 9,795,550 granted on 2017-10-24
US20160206540A1
Human necessities

Gamma-diketones for treatment and prevention of aging skin and wrinkles

#77 | 2016-05-12 ✅ Patent 9,381,192 granted on 2016-07-05
US20160128991A1
Human necessities

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

#78 | 2016-04-14 ✅ Patent 9,446,035 granted on 2016-09-20
US20160101092A1
Human necessities

1H-pyrazolo[3,4-]pyridines and therapeutic uses thereof

#79 | 2016-03-31 ✅ Patent 9,738,638 granted on 2017-08-22
US20160090380A1
Chemistry; metallurgy

2-(1H-indazol-3-yl)-3H-imidazo[4,5-B]pyridine and therapeutic uses thereof

#80 | 2016-03-17 ✅ Patent 9,475,807 granted on 2016-10-25
US20160075701A1
Chemistry; metallurgy

2-(1H-indazol-3-yl)-1H-imidazo[4,5-C]pyridine and therapeutic uses thereof

#81 | 2016-03-10 ✅ Patent 9,546,185 granted on 2017-01-17
US20160068551A1
Chemistry; metallurgy

3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

#82 | 2016-03-10 ✅ Patent 9,758,531 granted on 2017-09-12
US20160068550A1
Chemistry; metallurgy

3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof

#83 | 2016-03-10 ✅ Patent 9,493,487 granted on 2016-11-15
US20160068549A1
Chemistry; metallurgy

3-(1H-imidazo[4,5-C]pyridin-2-YL)-1H-pyrazolo[3,4-B]pyridine and therapeutic uses thereof

#84 | 2016-03-10 ✅ Patent 9,475,825 granted on 2016-10-25
US20160068548A1
Chemistry; metallurgy

3-(3H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

#85 | 2016-03-10 ✅ Patent 9,540,398 granted on 2017-01-10
US20160068547A1
Chemistry; metallurgy

3-(1h-imidazo[4,5-C]pyridin-2-yl)-1h-pyrazolo[3,4-C]pyridine and therapeutic uses thereof

#86 | 2016-03-10 ✅ Patent 9,657,016 granted on 2017-05-23
US20160068529A1
Chemistry; metallurgy

3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof

#87 | 2015-10-22 ✅ Patent 9,303,010 granted on 2016-04-05
US20150299174A1
Chemistry; metallurgy

β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators

#88 | 2015-10-22 ✅ Patent 9,493,437 granted on 2016-11-15
US20150299157A1
Chemistry; metallurgy

β- and γ-diketones and γ-hydroxyketones as / β-catenin signaling pathway activators

#89 | 2015-09-24 ✅ Patent 9,745,271 granted on 2017-08-29
US20150266825A1
Chemistry; metallurgy

5-substituted indazole-3-carboxamides and preparation and use thereof

#90 | 2015-06-04 ✅ Patent 9,199,991 granted on 2015-12-01
US20150152105A1
Chemistry; metallurgy

Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof

#91 | 2015-06-04 ✅ Patent 9,233,104 granted on 2016-01-12
US20150150862A1
Human necessities

1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof

#92 | 2015-03-12 ✅ Patent 9,012,472 granted on 2015-04-21
US20150072981A1
Chemistry; metallurgy

1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof

#93 | 2015-02-12 ✅ Patent 9,090,613 granted on 2015-07-28
US20150045379A1
Chemistry; metallurgy

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

#94 | 2015-02-12 ✅ Patent 9,067,939 granted on 2015-06-30
US20150045360A1
Chemistry; metallurgy

1H-pyrazolo[3,4-]pyridines and therapeutic uses thereof

#95 | 2014-10-30 ✅ Patent 8,901,150 granted on 2014-12-02
US20140323479A1
Chemistry; metallurgy

1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof

#96 | 2014-08-28 ✅ Patent 9,533,976 granted on 2017-01-03
US20140243349A1
Chemistry; metallurgy

γ-diketones as WNT/β-catenin signaling pathway activators

#97 | 2014-07-10 ✅ Patent 9,908,867 granted on 2018-03-06
US20140194441A1
Chemistry; metallurgy

3-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof

#98 | 2014-06-26 ✅ Patent 8,987,298 granted on 2015-03-24
US20140179696A1
Chemistry; metallurgy

Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof

#99 | 2014-03-20 ✅ Patent 8,921,413 granted on 2014-12-30
US20140080902A1
Chemistry; metallurgy

β- and γ-diketones and γ-hydroxyketones as / β-catenin signaling pathway activators

#100 | 2014-02-13 ✅ Patent 8,697,887 granted on 2014-04-15
US20140045815A1
Chemistry; metallurgy

Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors

Also check out Samumed, LLC's (San Diego, United States) applicant profile with 110 patent applications submitted.

AssigneeID:

9591 ⎘